Investors 2016-11-17T12:28:22+00:00


Investing in ViaCyte’s Future

Our shareholders include institutional investors as well as private individuals. We are pleased to have support from some of the world’s leading venture funds.

Our investors understand the complexities and uncertainties of our business, and they recognize that our technology has the potential to be vastly rewarding.
Anne Sandan, CPA, Vice President, Finance and Corporate Controller, ViaCyte

Major Institutional Investors

  • Johnson & Johnson Development Corporation
  • Sanderling Ventures
  • Asset Management
  • BD Ventures LLC
  • Hospira, Inc.
  • Portage Venture Partners
  • The Clayton Foundation